rabbit anti tfii i (Cell Signaling Technology Inc)
Cell Signaling Technology Inc is a verified supplier 
Cell Signaling Technology Inc manufactures this product 
86
Structured Review
Cell Signaling Technology Inc
rabbit anti tfii i
Rabbit Anti Tfii I, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/tfii+i/pmc12474925-526-7-12
Average 86 stars, based on 1 article reviews
Rabbit Anti Tfii I, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/tfii+i/pmc12474925-526-7-12
Average 86 stars, based on 1 article reviews
rabbit anti tfii i - by Bioz Stars,
2026-09
86/100 stars
Images
Related Articles
Incubation:Article Title: TFII-I and AP2α Co-Occupy the Promoters of Key Regulatory Genes Associated with Craniofacial Development. Article Snippet: Objectives: The aim of this study is to define the candidate target genes for TFII-I and AP2a regulation in neural crest progenitor cells.. Design: The GTF2I and GTF2IRD1 genes encoding the TFII-I family of transcription factors are prime candidates for the Williams-Beuren syndrome, a complex multisystem disorder characterized by craniofacial, skeletal, and neurocognitive deficiencies.. AP2a, a product of the TFAP2A gene, is a master regulator of neural crest cell lineage. Article Title: Genome-wide targeting of the epigenetic regulatory protein CTCF to gene promoters by the transcription factor TFII-I Article Snippet: .. The cells were then washed twice with PBS and blocked in blocking buffer (1× PBS, 1% BSA, 2% normal goat serum) for 60 min. Antibodies targeting CTCF (BD Biosciences catalog no. 612149; 1:50), Control:Article Title: Compositions and methods for Williams Syndrome (WS) therapy Article Snippet: Western blotting was performed and quantified using a Licor Odyssey CLx imaging system. .. Commercial antibodies used included Article Title: Neuronal deletion of Gtf2i, associated with Williams syndrome, causes behavioral and myelin alterations rescuable by a remyelinating drug. Article Snippet: 1McGovern Institute for Brain Research and Department of Brain & Cognitive Sciences, MIT, Cambridge, MA, USA.. 2The School of Psychological Sciences, Faculty of Social Sciences, Tel Aviv University, Tel Aviv, Israel.. 3The Sagol School of Neuroscience, Tel Aviv University, Tel Aviv, Israel. other:Article Title: Mutant GTF2I induces cell transformation and metabolic alterations in thymic epithelial cells Article Snippet: Five micrograms of the pLIX402 plasmids with mutated GTF2I isoforms were transfected into TEC100.4 cells using the Nucleofector Kit V (Lonza; Salisbury, MD, USA) with Nucleofector 2b device under T-30 program. Article Title: Compositions and methods for Williams Syndrome (WS) therapy Article Snippet: Images were captured using an Olympus Fluoview FV1000 confocal microscope. Blocking Assay:Article Title: Genome-wide targeting of the epigenetic regulatory protein CTCF to gene promoters by the transcription factor TFII-I Article Snippet: .. The cells were then washed twice with PBS and blocked in blocking buffer (1× PBS, 1% BSA, 2% normal goat serum) for 60 min. Antibodies targeting CTCF (BD Biosciences catalog no. 612149; 1:50), |